LawFuel.com – Best Law Newswire Service – PharMerica Corporation (NYSE: PMC) a national provider of institutional pharmacy specialty infusion and hospital pharmacy management services today issued the following statement:
“As previously disclosed in the Corporation’s 10-K and 10-Q Reports PharMerica Corporation is responding to investigations by the U.S. Attorneys and by the Drug Enforcement Agency into allegations that the Corporation failed to comply with various laws and regulations relating to the control and dispensing of certain controlled substances as well as the potential filing of false claims for payments of certain controlled substances that the Corporation dispensed to nursing home residents. The Corporation has been fully cooperative with the investigations. As part of these investigations on August 9 2013 the U.S. Department of Justice through the U.S. Attorney’s Office for the Eastern District of Wisconsin filed a complaint in the United States District Court for the Eastern District of Wisconsin against the Corporation alleging that the Corporation violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the Medicare program. The Corporation disputes the premises of this lawsuit and the related litigation and intends to vigorously defend itself against these allegations.”
PharMerica Corporation is a leading institutional pharmacy services company that services healthcare facilities in the United States provides pharmacy management services to hospitals and also provides specialty infusion services to patients outside a hospital setting. As of June 30 2013 PharMerica operated 90 institutional pharmacies and 12 specialty infusion centers in 45 states. PharMerica’s customers are institutional healthcare providers such as skilled nursing facilities nursing centers assisted living facilities hospitals individuals receiving in-home care and other long-term alternative care providers.